EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway

Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia iD, Marco Fiocchetti iD, Giovanna Iucci iD, Chiara Battocchio iD, Elisabetta Orlandini, Lidia Ciccone iD, Susanna Nencetti iD, Maurizio Muzzi, Sandra Moreno iD, Iole Venditti iD und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Emiliano Montalesi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, University Roma Tre, V.le G. Marconi, 446, 00146 Rome, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Prodrugs, Metal Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Universities and Research, Roma Tre University, Lazio Innova -Bandi per Gruppi di Ricerca 2020- NANORE’.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the first leading tumor in women in terms of incidence worldwide. Seventy percent of cases are estrogen receptor (ER) α-positive. In these malignancies, 17β-estradiol (E2) via ERα increases the levels of neuroglobin (NGB), a compensatory protein that protects cancer cells from stress-induced apoptosis, including chemotherapeutic drug treatment. Our previous data indicate that resveratrol (RSV), a plant-derived polyphenol, prevents E2/ERα-induced NGB accumulation in this cellular context, making E2-dependent breast cancer cells more prone to apoptosis. Unfortunately, RSV is readily metabolized, thus preventing its effectiveness. Here, four different RSV analogs have been developed, and their effect on the ERα/NGB pathway has been compared with RSV conjugated with highly hydrophilic gold nanoparticles as prodrug to evaluate if RSV derivatives maintain the breast cancer cells’ susceptibility to the chemotherapeutic drug paclitaxel as the original compound. Results demonstrate that RSV conjugation with gold nanoparticles increases RSV efficacy, with respect to RSV analogues, reducing NGB levels and enhancing the pro-apoptotic action of paclitaxel, even preventing the anti-apoptotic action exerted by E2 treatment on these cells. Overall, RSV conjugation with gold nanoparticles makes this complex a promising agent for medical application in breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProdrugsMetal NanoparticlesFemaleHumansNeuroglobinResveratrolEstrogen Receptor alphaGlobinsNerve Tissue ProteinsGoldEstradiolPaclitaxelCell Line, TumorApoptosisEstrogens

Stichwörter der Autor:innen

breast cancer cellsestrogen receptor αgold nanoparticlesresveratrolresveratrol analogs

Substanzen

NeuroglobinResveratrolEstrogen Receptor alphaProdrugsGlobinsNerve Tissue ProteinsGoldEstradiolPaclitaxelEstrogens

Autor:innen und Institutionen

  • Department of Science, University Roma Tre, V.le G. Marconi, 446, 00146 Rome, Italy.
  • IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano, 64, 00179, Rome, Italy.
  • Department of Earth Science, University of Pisa, Via Santa Maria, 53, 56126 Pisa, Italy.
  • Research Centre E. Piaggio, University of Pisa, 56122 Pisa, Italy.
  • Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.

ORCID-Profile: Filippo Acconcia, Marco Fiocchetti, Giovanna Iucci, Chiara Battocchio, Lidia Ciccone, Susanna Nencetti, Sandra Moreno, Iole Venditti, Maria Marino

Förderung

  • Ministry of Education, Universities and Research
  • Roma Tre University
  • Lazio Innova -Bandi per Gruppi di Ricerca 2020- NANORE’

Zitieren

APA

Montalesi, E., Cracco, P., Acconcia, F., Fiocchetti, M., Iucci, G., Battocchio, C., Orlandini, E., Ciccone, L., Nencetti, S., Muzzi, M., Moreno, S., Venditti, I., & Marino, M. (2023). Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032148

Vancouver

Montalesi E, Cracco P, Acconcia F, Fiocchetti M, Iucci G, Battocchio C, et al. Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032148

BibTeX
@article{Montalesi2023,
  author = {Montalesi, Emiliano and Cracco, Patrizio and Acconcia, Filippo and Fiocchetti, Marco and Iucci, Giovanna and Battocchio, Chiara and Orlandini, Elisabetta and Ciccone, Lidia and Nencetti, Susanna and Muzzi, Maurizio and Moreno, Sandra and Venditti, Iole and Marino, Maria},
  title = {Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032148}
}
Kostenlos starten →